December 12th 2024
Join Dermatology Times’ quarterly editor in chief Shanna Miranti, MPAS, PA-C, in a look back at acne milestones in 2024 such as topical clindamycin, adapalene, and benzoyl peroxide gel (Cabtreo).
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Treat acne to achieve remission
January 13th 2016There is an absence of strong evidence supporting the recommendation that cumulative dosing of isotretinoin follow a reference range of 120 to 150 mg/kg. This points to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.
Acne a growing problem in pre-teens
January 13th 2016Clinicians recognize that acne is increasingly presenting in pre-adolescents and that early presentation is also a predictor of worse disease in the future and the potential for scarring. Prompt, aggressive treatment will lead to better outcomes and will reduce the potential for adverse psychosocial effects.
Discoverers who advanced dermatology
December 15th 2015The stories of the heroes behind these and other dermatologic therapeutic discoveries are recounted in the book To Heal the Skin: The Heroes Behind Discoveries in Dermatology edited by the late Stuart Maddin, M.D., F.R.C.P.C., professor emeritus at the University of British Columbia (UBC) in Vancouver, Canada, and a leader and pioneer in dermatology in Canada and internationally, and Eileen Murray, M.D., F.R.C.P.C., a dermatologist and adjunct professor at UBC. Learn more
Should you wait after isotretinoin to treat acne with laser?
December 4th 2015Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
Partner content: Dr. Baldwin discusses the burden of acne
November 9th 2015Although acne is typically regarded as an adolescent condition, acne is aleso prevalent among adults. The limited data available on the clinical characteristics and burden of acne inspires Dr. Baldwin. In this short film, Dr. Baldwin describes the universal clinical characteristics and psychosocial impact of this skin condition.
Going beyond clinical guidelines for acne treatment
October 5th 2015Conventional acne treatment guidelines focus on acne severity. But there’s much more to effectively treating individual acne patients, according to an expert panel of 13 Canadian dermatologists, who developed a case-centered multifactorial consensus on acne management. Learn more
Isotretinoin’s discovery and development
September 17th 2015Dermatology Times editorial advisor Dr. Elaine Siegfried talks with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania about the art and science of isotretinoin therapy. Dr. Leyden, aside from being a member of the famed Acne Mafia, was a really active participant in the drug development process for isotretinoin, a drug for which, the institutional memory about that process may be fading. The two discuss many of the important initial clinical observations and those that others have made over the years.
Antibiotic-free treatment effective, safe for moderate-to-severe acne
July 20th 2015“The increased strength of adapalene (a retinoid) is a valuable ingredient to explore in view of the growing incidence of drug resistance and the fact that it apparently worked in moderate to severe acne patients is a very good sign," says an expert. Learn more.
My patient with acne committed suicide
June 2nd 2015A doctor who prescribed oral retinoids to an acne patient is sued by the patient's family after the patient commits suicide. The doctor's career, practice, reputation and everything he holds dear are at risk simply because he tried to be a good doctor. Should he try to defend himself? Will he lose the case at trial?